Differences

This shows you the differences between two versions of the page.

--- task_force_for_global_health [2022/04/20 20:06]
liam [Programs]
+++ task_force_for_global_health [2022/08/20 18:45] (current)
liam [Donors]
@@ Line 10: / Line 10: @@
 The Task Force has a wide portfolio of influential [[global health]] programs.
-| [[Brighton Collaboration]]  | [[Coalition for Global Hepatitis Elimination]]  |
+| [[Brighton Collaboration]]  | [[Children Without Worms]]  |
-| [[Coalition for Operational Research on Neglected Tropical Diseases]]  | [[Global Funders Consortium for Universal Influenza Vaccine Development]]  |
+| [[Coalition for Global Hepatitis Elimination]]  | [[CoVID-19 Vaccine Implementation Program]] (CoVIP)  |
-| [[Global Partnership for Zero Leprosy]]  | [[Mectizan Expert Committee]] (MEC)  |
+| [[Coalition for Operational Research on Neglected Tropical Diseases]]  | [[Focus Area for Compassion and Ethics]] (FACE)  |
+| [[Global Funders Consortium for Universal Influenza Vaccine Development]]  | [[Global Partnership for Zero Leprosy]]  |
+| [[Health Campaign Effectiveness Coalition]] (HCE)  | [[International Trachoma Initiative]] (ITI)  |
+| [[Mectizan Donation Program]] (MDP)  | [[Mectizan Expert Committee]] (MEC)  |
 | [[MedSurplus Alliance]]  | [[National Certification Committee]] (for safe handling and containment of all [[polioviruses]])  |
-| [[Partnerships for Influenza Vaccine Introduction]]  | [[Ready2Respond]]  |
+| [[Neglected Tropical Diseases Support Center]] (NTD-SC)  | [[Partnership for Influenza Vaccine Introduction]] (PIVI)  |
-| [[Soil-Transmitted Helminths Coalition]]  | [[Trachoma Expert Committee]] (TEC)  |
+| [[Polio Eradication Center]]  | [[Public Health Informatics Institute]] (PHII)  |
-| [[Training Programs in Epidemiology and Public Health Interventions Network]] (TEPHINET)  |
+| [[Ready2Respond]]  | [[Soil-Transmitted Helminths Coalition]]  |
+| [[Trachoma Expert Committee]] (TEC)  | [[Training Programs in Epidemiology and Public Health Interventions Network]] (TEPHINET)  |
+| [[Voices for Vaccines]] (VFV)  |
 Additionally, the Task Force launched their Council for Opportunity, Diversity and Equity (CODE) to "become a role model by being actively engaged in diversity and equity efforts, and to help foster a sense of belonging in our organization and community through education, action, and public health services."
@@ Line 23: / Line 28: @@
 ==== Leadership ====
-[[Teri McClure]] is the Board Chair, and [[Dave Ross]] is the President and Chief Executive Officer.((//Annual Report 2021.// The Task Force for Global Health. Retrieved April 20, 2022, from https://web.archive.org/web/20220215172458/https://www.taskforce.org/annual-report-2021/#section_2))
+[[Teri McClure]] is the Board Chair, and [[Dave Ross]] is the President and Chief Executive Officer.((//Annual Report 2021.// The Task Force for Global Health. Retrieved April 20, 2022, from https://web.archive.org/web/20220215172458/https://www.taskforce.org/annual-report-2021/#section_2)) The Board of Directors includes representatives from [[Atlantic Capital Bank]], [[Emory University School of Medicine]], [[Ernst & Young]], [[Evidation Health]], [[Hewlett Packard]], the [[Robert W. Woodruff Foundation]], and [[UPS]].
 ==== Partners ====
@@ Line 35: / Line 40: @@
 | [[UK Aid]]  | [[USAID]]  |
 | [[World Health Organization]] (WHO)  |
+==== Donors ====
+The Task Force has received donations from many [[pharmaceutical companies]] and other notable entities, including [[pharmaceutical_companies:Abbott]], [[pharmaceutical_companies:AbbVie]], [[American Endowment Foundation]], [[pharmaceutical_companies:Bayer]], the [[Bill & Melinda Gates Foundation]], [[BioScience]], [[Bruyere Research Institute]], [[Catholic Health Association]], [[Center for Compassionate Leadership]], [[Centers for Disease Control and Prevention]] (CDC), the [[CDC Foundation]], [[Center for Global Health Innovation]], the [[Coalition for Epidemic Preparedness Innovations]] (CEPI), [[Conrad N. Hilton Foundation]], [[medical_technology_companies:Dexcom]], [[Eagle Medical Services]], [[pharmaceutical_companies:Eisai]], [[Emory University]], [[pharmamceutical_companies:Genentech]], [[pharmaceutical_companies:Gilead Sciences]], [[pharmaceutical_companies:GlaxoSmithKline]], [[Hewlett Packard]], [[Hiroshima University]], [[International Federation of Pharmaceutical Manufacturers & Associations]] (IFPMA), [[Izumi Foundation]], [[pharmaceutical_companies:Johnson & Johnson]], [[Medical Bridges]], [[MedShare]], [[MedWish]], [[pharmaceutical_companies:Merck]], [[National Association of Chronic Disease Directors]], [[National Health Institute]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Pfizer]], [[Robert Wood Johnson Foundation]], [[pharmaceutical_companies:Roche]], [[Sanofi Espoir Foundation]], [[Scripps]], [[pharmaceutical_companies:Seqirus]], [[medical_technology_companies:Siemens Healthcare]], [[Stanford University]], [[Supplies Over Seas]], [[Templeton World Charity Foundation]], U.K. Foreign Commonwealth & Development Office ([[UK Aid]]), U.S. Agency for International Development ([[USAID]]), [[U.S. Department of State]], U.S. [[National Institutes of Health]] (NIH), [[United Nations Children’s Fund]], [[Wellcome Trust]], and the [[World Health Organization]] (WHO).((//Annual Report 2021.// The Task Force for Global Health. Retrieved April 20, 2022, from https://web.archive.org/web/20220215172458/https://www.taskforce.org/annual-report-2021/#section_2))
 ===== History =====